Trial Profile
A multicenter phase II trial of neo-adjuvant pemetrexed (Alimta) plus cisplatin followed by surgery and radiation for pleural mesothelioma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jan 2010
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- 10 Apr 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 09 Sep 2005 New trial record.